id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0117-0003,FDA,FDA-2011-E-0117,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-04-26T04:00:00Z,2011,4,2011-04-26T04:00:00Z,,2011-04-26T15:15:07Z,,0,0,0900006480c39815
FDA-2011-E-0117-0002,FDA,FDA-2011-E-0117,U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-02-25T05:00:00Z,2011,2,2011-02-25T05:00:00Z,,2013-08-11T01:40:08Z,,0,0,0900006480bf89ea
FDA-2011-E-0117-0001,FDA,FDA-2011-E-0117,Boehringer Ingelheim Corporation - Patent Term Extension Application,Other,APP-Application,2011-02-25T05:00:00Z,2011,2,2011-02-25T05:00:00Z,,2013-07-27T23:46:06Z,,0,0,0900006480bf89e9